Prof. Dr. İbrahim Yıldız
Medical Oncology
About İbrahim Yıldız
Prof. İbrahim Yıldız is a medical oncologist trained at Istanbul University, Istanbul Faculty of Medicine (2013). Since 2015 he has been practicing with the Acibadem Health Group, where he provides comprehensive oncology care with a strong focus on evidence-based treatment and patient-centered communication. An active member of the international oncology community, he belongs to the European Society for Medical Oncology and the American Society of Clinical Oncology. He also serves on the Board of the Lung Cancer Association and is a member of the Turkish Society of Medical Oncology. His clinical interests include thoracic malignancies and the integration of emerging systemic therapies into multidisciplinary treatment plans. Known for his collaborative approach, he works closely with surgical, radiation, and supportive care teams to optimize outcomes and quality of life for his patients.
Subspecialties
- Lung cancer
- Thoracic malignancies
- Colorectal cancer
- Metastatic colorectal cancer
- Stage II colon cancer
- Esophageal cancer
- Triple-negative breast cancer
- HER2-positive breast cancer
- Testicular germ cell tumors
- Testicular seminoma
- Adjuvant chemotherapy
- Cisplatin plus fluorouracil chemotherapy
- Platinum-based chemotherapy
- Tamoxifen therapy
Education
- 2013 Istanbul University Istanbul Faculty of Medicine Medical Oncology
- 2006 Istanbul University Cerrahpaşa Faculty of Medicine Internal Medicine
- 2003 Istanbul University Cerrahpasa Faculty of Medicine
Experience
- 2015 Acibadem Health Group
- 2013 – 2015 Izmir Katip Çelebi University Atatürk Training and Research Hospital / Medical Oncology Clinic
- 2009 – 2010 War Academies Command / Military Service
- 2007 – 2009 Kağıthane State Hospital / Compulsory Service
Professional Memberships
- European Society of Medical Oncology
- Lung Cancer Association Board Member
- Turkish Society of Medical Oncology
- American Society of Clinical Oncology
Selected Publications
- Evaluation of c-kit (CD 117) expression as a prognostic factor in testicular germ cell tumors: An Izmir Oncology Group (IZOG) study. J BUON. 2015 Jul-Aug;20(4):1054-60 Salman T, Yildiz E, Yildiz I, Yavuzer D, Unlu M, Varol U, Akyol M, Yildiz Y, Bayoglu V, Kucukzeybek Y, Alacacioglu A
- Quality of life in colorectal cancer patients: an Izmir Oncology Group (IZOG) study. J BUON. 2015 Jul-Aug;20(4):1015-22. Akyol M, Ulger E, Alacacioglu A, Kucukzeybek Y, Bayoglu V, Yildiz Y, Yildiz I, Salman T, Varol U, Demir L, Dirican A, Gumus Z, Oktay Tarhan M.
- First-line cisplatin plus bolus 5- Fluorouracil combination in patients with locally advanced and metastatic esophageal cancer (Izmir Oncology Group study) Ahmet Alacacioglu, Mustafa Oktay Tarhan. Acta Oncol Tur. 2015; 48(1): 20-26 DOI: 10.5505/aot.2015.92408 Murat Akyol, Yüksel Küçükzeybek, Umut Varol, Ibrahim Yıldız, Suna Çokmert, İbrahim Vedat Bayoğlu, Yaşar Yıldız, Lutfiye Demir, Alper Can,Ahmet Dirican
- Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers. Biomedicine & pharmacotherapy,2015 IV Bayoglu , BB Kucukzeybek , Y Kucukzeybek , U Varol , I Yildiz , A Alacacioglu , M Akyol , L Demir , A Dirican , Y Y Yildiz , T Salman , MO Tarhan.
- Adjuvant Chemotherapy and Prognostic Factors in Stage II Colon Cancer Varol Umut , Salman Tarik , Yildiz Ibrahim , Can Huseyin , Tarhan Mustafa Oktay Asian Pac J Cancer Prev vol 16, 2015, DOI:http://dx.doi.org/10.7314/APJ Kucukzeybek Yuksel , Dirican Ahmet , Demir Lutfiye , Yildirim Serkan , Akyol Murat , Yildiz Yasar , Bayoglu Ibrahim Vedat , Alacacioglu Ahmet ,
- D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients. Cancer Biomark. 2015 Kilic L, Yildiz I, Sen FK, Erdem MG, Serilmez M, Keskin S, Ciftci R, Karabulut S, Ordu C, Duranyildiz D, Tas F.
- Sexual satisfaction, anxiety, depression and quality of life among Turkish colorectal cancer patients (Izmir Oncology Group (IZOG) study. Tarhan Mustafa Oktay.Japanese journal of clinical oncology,2015. Akyol Murat, Ulger Eda, Alacacioglu Ahmet, Kucukzeybek Yuksel, Yildiz Yasar, Gumus Zehra, Yildiz Ibrahim, Salman Tarik, Varol Umut, Ayakdas Semra,
- The Effect of Tamoxifen on Anxiety, Depression, Quality of Life and Sexual Satisfaction in a Premenopausal Breast Cancer Patient. İnci Alacacıoğlu , Mustafa Oktay Tarhan. Ahmet Alacacıoğlu, Eda Ülger, Umut Varol, İbrahim Yıldız, Tarık Salman, Vedat Bayoğlu, Ahmet Dirican, Murat Akyol, Yaşar Yıldız, Yüksel Küçükzeybek,
- Potential curative role of chemotherapy in patients with metastatic colorectal cancer with complete response to first-line chemotherapy. Acta Oncologica Turcica Varol Umut, Alacacioglu Ahmet, Yildiz Ibrahim, Tarhan Mustafa Oktay
- Multiple arterial occlusions precipitated by platinum based chemotherapy in a patient with testicular seminoma Journal-Cardiovascular Surgery, 1, Doi: 10.5455/jcvs.20131×12 Sen Fatma, Karavelioglu Yusuf, Yildiz Ibrahim, Sahin Dilek, Bavbek Sevil
Schedule your appointment with Prof. Dr. İbrahim Yıldız
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.